MIRA INFORM REPORT

 

 

Report No. :

312483

Report Date :

30.04.2015

 

IDENTIFICATION DETAILS

 

Name :

NARANG BIOTEC PRIVATE LIMITED

 

 

Registered Office :

6943/2, Jaipuria Building, Kolhapur Road, Kamla Nagar, Delhi – 110007

Tel. No.:

91-11-32320921/23859003/4

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

30.03.2012

 

 

Com. Reg. No.:

55-233785

 

 

Capital Investment / Paid-up Capital :

Rs. 2.500 Million

 

 

CIN No.:

[Company Identification No.]

U24100DL2012PTC233785

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of pharma products.

 

 

No. of Employees :

15 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

For the financial year 2014, sales turnover of the company has increased over previous and company has achieved nearly 78%  topline growth.

 

Evern though company has shown decent topline growth but it fails to maintain profitability margins and profitability stood at 0.049%. Further reserves of the company is low and due to which net worth position of the company is weak.

 

However, trade relations are reported fair. Payment are reported to be slow but correct.

 

In view of moderate financial profile, the company can be considered for business dealing with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Rakesh Narang

Designation :

Director

Contact No.:

91-9810014268

Date :

24.04.2015

 

 

LOCATIONS

 

Registered Office/ Head Office :

6943/2, Jaipuria Building, Kolhapur Road, Kamla Nagar, Delhi – 110007, India

Tel. No.:

91-11-32320921

Mobile No.:

91-9810014268 (Mr. Rakesh Narang)

Fax No.:

Not Available

E-Mail :

narang.rakesh@gmail.com

hirabansal@yahoo.com

narangbiotec@gmail.com

Area :

1000 Sq. ft.

Location :

Owned

 

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Rakesh Narang

Designation :

Director

Address :

14-35, Shakti Nagar, Delhi – 110007, India

Date of Birth/Age :

13.01.1960

Date of Appointment :

30.03.2012

PAN No.:

05228365

 

 

Name :

Anuj Narang

Designation :

Director

Address :

14-35, Shakti Nagar, Delhi – 110007, India

Date of Birth/Age :

21.04.1991

Date of Appointment :

30.03.2012

PAN No.:

05228373

 

 

Name :

Sushma Narang

Designation :

Director

Address :

14-35, Shakti Nagar, Delhi – 110007, India

Date of Birth/Age :

10.08.1960

Date of Appointment :

21.05.2012

PAN No.:

05285768

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Shareholders

No. of Shares

Percentage of Holding

Rakesh Narang

180000

72.00

Anuj Narang

50000

20.00

Sushma Narang

20000

8.00

 

 

 

Total

250000

100.00

 

 

 

AS ON 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of pharma products.

 

 

Products :

Not Available

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Parvati Pharma

Name of the Person :

Mr. Bhupender Kumar (Partner)

Contact No.:

91-9811848801

Since How Long Known :

5 Years

Experience :

Payment Behiour : Good, Market Goodwill : Excellent, Overall : Excellent

Maximum Limit Dealt :

Rs. 0.500 Million

Remark :

They had a good experience with subject company. As claimed by Mr. Bhupender Kumar (Partner) payment behavior are good.

  • Concept  Pharmaceuticals Limited, Mumbai, Maharashtra, India

 

 

Customers :

Reference :

H.R. Pharma

Name of the Person :

Mr. Rajesh Kumar (Proprietor)

Contact No.:

91-9810408008

Since How Long Known :

20 Years

Experience :

Excellent

Maximum Limit Dealt :

Not Divulged

Remark :

They are satisfied with product quality  and delivery behavior.

  • Helpline Pharmacy, New Delhi, India

 

 

No. of Employees :

15 (Approximately)

 

 

Bankers :

Banker Name

Coroporation Bank

Branch Address

Kamla Nagar, Delhi, India

Person Name (With Designation)

Mr. Y.P. Rao (A.G.M.)

Contact Number

91-9953333262

Name of Account Holder

Narang Biotec Private Limited

Account Number

CVPOD120007

Account Since (Date/Year of Account Opening)

29th December 2012

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Overdraft Rs. 14.800 Million

Account Operation

Good

Remarks (If any)

Banker gave us positive feedback. As claimed by Mr. Y.P. Rao (AGM) that subject having very good track reocord for banking transaction.

  • ICICI Bank  Limited, Kamla Nagar, New Delhi, India

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

LONG TERM BORROWINGS

 

 

Car loan form Corporation Bank

0.725

0.884

Loan and advances from related parties

0.545

0.000

SHORT TERM BORROWINGS

 

 

Bank OCC from Corporation Bank

9.391

0.499

 

 

 

Total

10.661

1.383

 

 

 

Auditors :

 

Name :

H L Bansal and Company

Chartered Accountants

Address :

23/4, Chadha Bahwan, Shakti Nagar, Delhi – 110007, India

PAN No.:

AAAPB2797D

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

  • Narang  Chemist
  • AN Enterprises

 

CAPITAL STRUCTURE

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

250000

Equity Shares

Rs. 10/- each

Rs. 2.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

250000

Equity Shares

Rs. 10/- each

Rs. 2.500 Million

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

2.500

2.500

(b) Reserves & Surplus

 

0.271

0.129

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

2.771

2.629

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

1.270

0.884

(b) Deferred tax liabilities (Net)

 

0.000

0.006

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

1.270

0.890

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

9.391

0.569

(b) Trade payables

 

38.008

38.154

(c) Other current liabilities

 

0.090

0.406

(d) Short-term provisions

 

0.110

0.065

Total Current Liabilities (4)

 

47.599

39.194

 

 

 

 

TOTAL

 

51.640

42.713

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1.133

1.426

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.028

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

1.161

1.426

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

1.064

6.000

(b) Inventories

 

19.406

11.861

(c) Trade receivables

 

29.924

21.658

(d) Cash and cash equivalents

 

0.001

1.629

(e) Short-term loans and advances

 

0.037

0.000

(f) Other current assets

 

0.047

0.139

Total Current Assets

 

50.479

41.287

 

 

 

 

TOTAL

 

51.640

42.713

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

 

287.719

161.097

 

 

Other Income

 

NA

NA

 

 

TOTAL                                    

 

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

 

NA

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX 

 

NA

NA

 

 

 

 

 

Less

TAX                                                                 

 

NA

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

0.142

0.139

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 

0.57

0.56

 

 

Expected Sales (2014-15): Rs. 280.000 Million

 

The above information has been parted by Mr. Rakesh Narang (Director)

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2014

 

31.03.2013

 

 

 

 

 

Net Profit Margin

PAT / Sales

(%)

 

0.05

0.09

 

 

 

 

 

Debt Equity Ratio

(Total Debts/Networth)

 

 

3.85

0.55

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.06

1.05

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

2.500

2.500

Reserves & Surplus

0.129

0.271

Net worth

2.629

2.771

 

 

 

long-term borrowings

0.884

1.270

Short term borrowings

0.569

9.391

Total borrowings

1.453

10.661

Debt/Equity ratio

0.553

3.847

 

 

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

Sales

161.097

287.719

 

 

78.600

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

Sales

161.097

287.719

Profit

0.139

0.142

 

0.09%

0.05%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

-------

22]

Litigations that the firm / promoter involved in

-------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

Yes

26]

Buyer visit details

--------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10401656

29/12/2012

14,800,000.00

CORPORATION BANK

E-28, SUNDER BHAWAN, KAMLA NAGAR, DELHI,

Delhi - 110007,

INDIA

B67500330

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

SHORT TERM BORROWINGS

 

 

Unsecured loans from Directors and Shareholers

0.000

0.070

 

 

 

Total

0.000

0.070

 

 

 

 

 

 

 

FIXED ASSETS

 

  • Furniture and Fixture
  • Invertor
  • Computer
  • Office Equipments

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 63.40

UK Pound

1

Rs. 95.42

Euro

1

Rs. 68.49

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

JYO


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILITY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.